Live Quote · NASDAQOMICHealthcare· Medical - Instruments & Supplies

Singular Genomics Systems, Inc.

$20.01 0.00%(+$0.00)
TickerSpark Score
63/100
Mixed
53
Valuation
20
Profitability
60
Growth
80
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OMIC research report →

52-Week Range81% of range
Low
$5.34
Current
$20.01
High
$23.41
Company Overviewsingulargenomics.com

About the company

Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements.

CEO
Andrew Spaventa
IPO
2021
Employees
255
HQ
La Jolla, CA, US

Price Chart

+30.78% · this period
$23.30$14.48$5.65Feb 21Aug 21Feb 21
Valuation
Market Cap
$50.77M
P/E
-0.51
P/S
17.44
P/B
0.27
EV/EBITDA
-1.27
Div Yield
0.00%
Profitability
Gross Margin
-19.17%
Op Margin
-3531.47%
Net Margin
-3257.30%
ROE
-43.17%
ROIC
-39.13%
Growth & Income
Revenue
$2.91M · 280.52%
Net Income
$-94,820,000 · -7.42%
EPS
$-39.08 · -5.00%
Op Income
$-102,801,000
FCF YoY
19.87%
Performance & Tape
52W High
$23.41
52W Low
$5.34
50D MA
$19.81
200D MA
$14.23
Beta
1.83
Avg Volume
13.41K

Get TickerSpark's AI analysis on OMIC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 21, 25TANG KEVINsell372,000
Feb 21, 25Spaventa Andrewsell5,271
Feb 21, 25Spaventa Andrewsell42,881
Feb 21, 25Spaventa Andrewsell85
Feb 21, 25Spaventa Andrewsell15,555
Feb 21, 25Spaventa Andrewsell22,874
Feb 21, 25Spaventa Andrewsell33,333
Feb 21, 25Meeter Dalensell6,666
Feb 21, 25Meeter Dalensell1,874
Feb 21, 25Meeter Dalensell6,249
Coverage · OMIC

Our OMIC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on OMIC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate OMIC report →
Internal Compare

Similar companies

Peers in the same neighborhood.